NCT05299840 - Impact of Using the Oncogramme® Device to Select the First Line of Treatment for Patients With Metastatic Colorectal Cancer | Biotech Hunter

Enrollment

450

Participants

Timeline

Start Date

June 7, 2023

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions

Metastatic Colorectal Cancer

Interventions

DIAGNOSTIC_TEST

Oncogramme results available

in vitro analysis of each patient's tumor cells in order to compare the responses of the tumor cells to the different molecules and therapeutic combinations available

DIAGNOSTIC_TEST

Oncogramme results unavailable

in vitro analysis of each patient's tumor cells in order to compare the responses of the tumor cells to the different molecules and therapeutic combinations available

Trial Locations (1)

13008

RECRUITING

Hôpital Saint Joseph Marseille, Marseille